no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Abuse liability assessment of CNS drugs: conclusions, recommendations, and research priorities
|
|
|
2003 |
70 |
3S |
p. S107-S114 8 p. |
article |
2 |
Assessing abuse liability in clinical trials
|
Brady, Kathleen T. |
|
2003 |
70 |
3S |
p. S87-S95 9 p. |
article |
3 |
Conference on abuse liability assessment of CNS drugs
|
Schuster, Charles R. |
|
2003 |
70 |
3S |
p. S1-S4 4 p. |
article |
4 |
Editorial Board
|
|
|
2003 |
70 |
3S |
p. IFC- 1 p. |
article |
5 |
Guidelines and methodological reviews concerning drug abuse liability assessment
|
Balster, Robert L. |
|
2003 |
70 |
3S |
p. S13-S40 28 p. |
article |
6 |
Incorporating the assessment of abuse liability into the drug discovery and development process
|
Mansbach, Robert S. |
|
2003 |
70 |
3S |
p. S73-S85 13 p. |
article |
7 |
Keeping the lid on: a century of drug regulation and control
|
Spillane, Joseph |
|
2003 |
70 |
3S |
p. S5-S12 8 p. |
article |
8 |
Postmarketing surveillance for drug abuse
|
Arfken, Cynthia L. |
|
2003 |
70 |
3S |
p. S97-S105 9 p. |
article |
9 |
Principles of drug abuse liability assessment in laboratory animals
|
Ator, Nancy A. |
|
2003 |
70 |
3S |
p. S55-S72 18 p. |
article |
10 |
Principles of initial experimental drug abuse liability assessment in humans
|
Griffiths, Roland R. |
|
2003 |
70 |
3S |
p. S41-S54 14 p. |
article |